Department of Oncology, The First Affiliated Hospital of Nanchang University , Nanchang, Jiangxi Province, P. R China.
Department of Infectious Diseases & Key Laboratory of Liver Regenerative Medicine of Jiangxi Province, The First Affiliated Hospital of Nanchang University , Nanchang, Jiangxi Province, P. R China.
Cancer Biol Ther. 2020 Nov 1;21(11):1041-1050. doi: 10.1080/15384047.2020.1824478. Epub 2020 Oct 21.
In this study, we explored the ability of TAMs to affect the malignant phenotype of human hepatoma Huh-7 cells through the Gli2/IGF-II/ERK1/2 pathway.
The TAMs were characterized by flow cytometry and ELISA assays. Huh-7 cells were treated with conditioned medium of TAMs (TAMs-CM), and the proliferation, migration and invasion abilities were measured by CCK-8, Transwell and scratch assays. The levels of TGF-β1, Gli2, IGF-II and related proteins in the ERK1/2 pathway and the epithelial-mesenchymal transition (EMT) process were examined by RT-qPCR and western blot. Huh-7 cells were injected subcutaneously into nude mice with TAMs to explore the role of TAMs in tumor growth.
The expression levels of TGF-β1, Gli2 and IGF-II and the cell proliferation, migration and invasion abilities were elevated in Huh-7 cells treated with TAMs-CM. TGF-β1 was upregulated in the conditioned medium and was found to be involved in the promotion of migration, invasion and the EMT of Huh-7 cells. The activation of TGF-β1 signaling increased the expression of Gli2. Knockdown of Gli2 decreased the expression of IGF-II and also reversed the promotional effect of the conditioned medium on migration, invasion and the EMT of Huh-7 cells. TGF-β1/Gli2/IGF-II signaling was shown to promote the malignant phenotype of Huh-7 cells by activating the ERK1/2 signaling pathway. Further, TGF-β1 knockdown attenuated the influence of TAMs on tumor growth in mouse model.
The TGF-β1 secreted by TAMs promotes the migration, invasion and EMT of human hepatoma Huh-7 cells through the Gli2/IGF-II/ERK1/2 pathway.
本研究旨在探讨肿瘤相关巨噬细胞(TAMs)通过Gli2/IGF-II/ERK1/2 通路影响人肝癌 Huh-7 细胞恶性表型的能力。
采用流式细胞术和 ELISA 法对 TAMs 进行鉴定。用 TAMs 条件培养基(TAMs-CM)处理 Huh-7 细胞,通过 CCK-8、Transwell 和划痕实验检测细胞增殖、迁移和侵袭能力。采用 RT-qPCR 和 Western blot 检测 ERK1/2 通路和上皮间质转化(EMT)过程中 TGF-β1、Gli2、IGF-II 及相关蛋白的水平。将 TAMs 与人肝癌 Huh-7 细胞共注射入裸鼠皮下,以探讨 TAMs 在肿瘤生长中的作用。
TAMs-CM 处理的 Huh-7 细胞中 TGF-β1、Gli2 和 IGF-II 的表达水平以及细胞增殖、迁移和侵袭能力均升高。TAMs 条件培养基中 TGF-β1 表达上调,并参与促进 Huh-7 细胞迁移、侵袭和 EMT。TGF-β1 信号的激活增加了 Gli2 的表达。Gli2 敲低降低了 IGF-II 的表达,并逆转了条件培养基对 Huh-7 细胞迁移、侵袭和 EMT 的促进作用。TGF-β1/Gli2/IGF-II 信号通过激活 ERK1/2 信号通路促进 Huh-7 细胞的恶性表型。此外,TGF-β1 敲低减弱了 TAMs 对小鼠模型中肿瘤生长的影响。
TAMs 分泌的 TGF-β1 通过 Gli2/IGF-II/ERK1/2 通路促进人肝癌 Huh-7 细胞的迁移、侵袭和 EMT。